These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6710555)

  • 1. Evaluation of an ultrafiltration-fluorescence polarization immunoassay for monitoring unbound phenytoin.
    Argyle JC; Kinniburgh DW; Costa R; Jennison T
    Ther Drug Monit; 1984; 6(1):117-20. PubMed ID: 6710555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for the quantitative determination of phenytoin, phenobarbitone and carbamazepine in serum.
    Ashy AR; el-Sayed YM; Islam SI
    J Pharm Pharmacol; 1986 Aug; 38(8):572-7. PubMed ID: 2876072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of total and free phenytoin in serum by non-isotopic immunoassays and gas chromatography.
    Külpmann WR; Gey S; Beneking M; Kohl B; Oellerich M
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):773-9. PubMed ID: 6396367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal.
    Roberts WL; Rainey PM
    Clin Chem; 1993 Sep; 39(9):1872-7. PubMed ID: 8375063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin free fraction determination: comparison of an improved direct serum injection high-performance liquid chromatographic method to ultrafiltration coupled with fluorescence polarization immunoassay.
    Gurley BJ; Marx M; Olsen K
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):358-64. PubMed ID: 8548029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
    Dasgupta A; Havlik D
    Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite and matrix interference in phenytoin immunoassays.
    Rainey PM; Rogers KE; Roberts WL
    Clin Chem; 1996 Oct; 42(10):1645-53. PubMed ID: 8855149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera.
    Tiula E
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):51-5. PubMed ID: 6717171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a free phenytoin assay on Cobas c501 analyzer using calibrators from Cobas Integra free phenytoin assay by comparing its performance with fluorescence polarization immunoassay for free phenytoin on the TDx analyzer.
    Dasgupta A; Davis B; Chow L
    J Clin Lab Anal; 2013 Jan; 27(1):1-4. PubMed ID: 23325740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors.
    Biddle DA; Wells A; Dasgupta A
    Life Sci; 2000; 66(2):143-51. PubMed ID: 10666010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-patient rapid assay of phenytoin concentration.
    Scheyer RD; Hochholzer JM; Mattson RH
    Epilepsia; 1995 Nov; 36(11):1152-4. PubMed ID: 7588461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds.
    Dasgupta A; Abu-Alfa A
    Am J Clin Pathol; 1992 Jul; 98(1):19-25. PubMed ID: 1615921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Amicon Centrifree micropartition system with the Sartorius SM 13249E Centrisart I device to determine protein free phenytoin concentrations.
    Zysset T; Zeugin T
    Ther Drug Monit; 1986; 8(3):346-51. PubMed ID: 3529518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
    Oeltgen PR; Shank WA; Blouin RA; Clark T
    Ther Drug Monit; 1984; 6(3):360-7. PubMed ID: 6390799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in saliva.
    Miles MV; Tennison MB; Greenwood RS; Benoit SE; Thorn MD; Messenheimer JA; Ehle AL
    Ther Drug Monit; 1990 Sep; 12(5):501-10. PubMed ID: 2293415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of total drug concentration on the free fraction in uremic sera.
    Tiula E; Neuvonen PJ
    Ther Drug Monit; 1986; 8(1):27-31. PubMed ID: 3961893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin.
    Melten JW; Wittebrood AJ; Willems HJ; Faber GH; Wemer J; Faber DB
    J Pharm Sci; 1985 Jun; 74(6):692-4. PubMed ID: 4020659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.